Microbial factories for recombinant pharmaceuticals

Most of the hosts used to produce the 151 recombinant pharmaceuticals so far approved for human use by the Food and Drug Administration (FDA) and/or by the European Medicines Agency (EMEA) are microbial cells, either bacteria or yeast. This fact indicates that despite the diverse bottlenecks and obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrer-Miralles, Neus, Domingo-Espín, Joan, Corchero, José Luis, Vázquez, Esther, Villaverde, Antonio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669800/
https://www.ncbi.nlm.nih.gov/pubmed/19317892
http://dx.doi.org/10.1186/1475-2859-8-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669800/
https://www.ncbi.nlm.nih.gov/pubmed/19317892
http://dx.doi.org/10.1186/1475-2859-8-17

Ejemplares similares